Customize doses according to labs, monitor side effects, and use peptide types supported by research
Research shows that 81% of employers acknowledge the interest of employees in GLP-1 coverage, but only 25% actually offer it, leading to a significant disparity between employee demand and employer offerings
reported in a propensity score-matched population-based cohort analysis that GLP-1 receptor agonist use in patients with MASLD and type 2 diabetes was associated with a lower risk of HCC (aHR: 0.55, 95%CI: 0.44-0.69) and all-cause mortality (aHR: 0.62, 95%CI: 0.55-0.71) [59]
Store food supplements out of the reach of small children
As a result, clinicians and patients questioned the long-term safety of agents such as exenatide, liraglutide, semaglutide, and dulaglutide
Rubes J, Selevan SG, Sram RJ et al (2007) GSTM1 genotype influences the susceptibility of men to sperm DNA damage associated with exposure to air pollution